Eliem Therapeutics
Biotechnology ResearchView the employees at
Eliem Therapeutics-
Jason Ramseth VP and Head of Information Technology
-
Paradise Valley
-
Top 5%
Nicholas Nebbeling Associate Director, Technical Accounting & Financial Reporting at Eliem Therapeutics-
Top 10%
Scott Gibson Director, Drug Substance at Eliem Therapeutics | MChem | PhD | MBA | CChem FRSC-
Beverley, England, United Kingdom
-
Top 5%
Julian Waterworth Director, Drug Product at Eliem Therapeutics-
St Albans, England, United Kingdom
-
Rising Star
Scott Gibson Director, Drug Substance at Eliem Therapeutics | MChem | PhD | MBA | CChem FRSC-
Beverley, England, United Kingdom
-
Rising Star
Overview
Eliem Therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. Locations in US, with R&D operations in Cambridge, UK, Eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. These conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives. Eliem is a publicly traded company (NASDAQ: ELYM) Read our community guidelines here: https://eliemtx.com/community-engagement-guidelines/
-